APRINOIA THERAPEUTICS
APRINOIA is a late-stage biotechnology company committed to protecting patients' brain health and changing outcomes of neurodegenerative diseases through first-in-class and best-in-class diagnostic tools and novel therapies. The company aims to bring precision medicine to neuroscience by identifying and targeting the protein aggregates of tau, alpha-synuclein and other proteins that play a critical role in the pathogenesis of many neurodegenerative diseases, such as Alzheimer's and Parkinson's Diseases. The company currently has operations in Hong Kong, Suzhou, Shanghai, Tokyo, and Boston.
APRINOIA THERAPEUTICS
Industry:
Biotechnology Health Diagnostics Medical Therapeutics
Founded:
2015-05-20
Address:
Hong Kong, Hong Kong Island, Hong Kong
Country:
Hong Kong
Website Url:
http://www.aprinoia.com
Total Employee:
51+
Status:
Active
Contact:
+1-617-225-4415
Email Addresses:
[email protected]
Total Funding:
57.53 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Disarm Therapeutics
Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.
Current Advisors List
Current Employees Featured
Founder
Investors List
IMM Private Equity
IMM Private Equity investment in Series C - APRINOIA Therapeutics
KTB Network
KTB Network investment in Series C - APRINOIA Therapeutics
Yantai Dongcheng Pharmaceutical
Yantai Dongcheng Pharmaceutical investment in Series C - APRINOIA Therapeutics
KTB Network
KTB Network investment in Series B - APRINOIA Therapeutics
DCI Partners
DCI Partners investment in Series B - APRINOIA Therapeutics
TaiAn Technologies
TaiAn Technologies investment in Series B - APRINOIA Therapeutics
ShangPharma
ShangPharma investment in Series B - APRINOIA Therapeutics
Official Site Inspections
http://www.aprinoia.com Semrush global rank: 6.79 M Semrush visits lastest month: 788
- Host name: cloudproxy10054.sucuri.net
- IP address: 192.124.249.54
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago